Background: Some but not all past studies reported associations between components of air pollution and breast cancer, namely fine particulate matter 2.5 mm (PM 2.5 ) and nitrogen dioxide (NO 2 ). It is yet unclear whether risks differ according to estrogen receptor (ER) and progesterone receptor (PR) status.
95% CI, 0.97-1.07), the association with NO 2 differed according to ER/PR subtype (P ¼ 0.04). For an interquartile range (IQR) difference of 5.8 parts per billion (ppb) in NO 2 
Introduction
Several studies suggest an association between breast cancer risk and exposure to ambient fine-particulate matter (PM 2.5 ) and nitrogen dioxide (NO 2 ), a marker of traffic-related air pollution (1) (2) (3) 
Materials and Methods
The Sister Study, a cohort of 50,884 U.S. women between ages 35 to 74 whose sister had breast cancer (5), enrolled participants from August 2003 to July 2009, who were followed for a mean of 4.95 years. Two thousand and eighty-nine breast cancer cases arose between enrollment and January 2013, (of which 316 were in situ), with a mean time to breast cancer of 3.96 years. Air pollution exposure was not ascertained on 1,234 women (24 invasive and 6 in situ; 1,204 noncases) predominantly because they lived outside the conterminous U.S., resulting in 1,749 invasive breast cancers and 47,591 noncases for this analysis. Annual averages of air pollution concentration outside the residence were estimated at each participant's home from a validated regionalized universal kriging model derived from regulatory monitors and a large suite of geographic covariates using previously described methods (6) . For primary analyses, air pollution estimates were based on annual average concentrations at baseline home addresses, derived using monitoring data from 2006 (PM 2.5 and NO 2 ) and 2000 (PM 10 ). The cross-validated R 2 for PM 2.5 NO 2 , and PM 10 were 0.88, 0.85, and 0.53, respectively (6) . HR and 95% CI were estimated using Cox proportional hazards models. Known breast cancer risk factors were considered for inclusion in the model if the factor was associated with both air pollution and breast cancer. Race, educational attainment, smoking status, and menopausal hormone therapy met these criteria.
Results were unchanged when we adjusted for geography using splines. In subset analyses, (i) we examined the effect of air pollution separately for breast cancer subtypes, stratifying by estrogen receptor/progesterone receptor (ER/PR) and stage, calculating RR and 95% CI using polytomous logistic regression; and (ii) we examined residential air pollution concentrations derived from 1990's estimates among those who had lived long-term at their current residence (i.e., excluding those who changed residences) in order to investigate associations of long-term air pollution with breast cancer.
Results
Breast cancer cases were more likely White, highly educated, and users of menopausal hormone therapy (Table 1) . There was no association between invasive breast cancer overall and PM 2.5 , PM 10 , or NO 2 (Table 2) . However, the risk associated with NO 2 differed when stratified by ER/PR (P ¼ 0.04). NO 2 
4).
This analysis using a prospective, large national sample that systematically evaluated air pollution using state-of-the-art spatial modeling is able to rule out a strong relationship between air pollution and breast cancer risk. One limitation is that air pollution exposure earlier in life could affect breast cancer risk; however, our analysis of long-term air pollution exposure showed results were unchanged. Replication of these results is needed before firm conclusions can be drawn regarding ER þ /PR þ breast cancer risk in relation to traffic-related air pollution. 
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